CORRECTION: On Friday, Xenetic Biosciences Q4 GAAP EPS $(0.77) Beats $(0.87) Estimate, Sales $671.96K Miss $680.00K Estimate

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.87) by 11.49 percent. This is a 23 percent increase over losses of $(1

BenzingaMar 25 18:59

Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo FinanceMar 24 21:38

Xenetic Biosciences, Inc. Under Pressure: Shareholder Activism Threatens Stability and Financial Future

TipRanksMar 23 14:00

Analysts' Opinions Are Mixed on These Healthcare Stocks: Xenetic Biosciences (XBIO) and Dianthus Therapeutics (DNTH)

TipRanksMar 22 20:31

Xenetic Biosciences Reports FY Results

Seeking AlphaMar 22 20:14

Xenetic Biosciences Q4 EPS $0.77 Beats $(0.87) Estimate, Sales $671.96K Miss $680.00K Estimate

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $(0.87) by 188.51 percent. This is a 177 percent increase over losses of $

BenzingaMar 22 20:03